BioHealth News Archive
MedImmune leads $12.5M round for new drug aimed at big chemo market – FierceBiotech
MedImmune's venture arm has jumped in to lead a $12.5 million round for a Chapel Hill, NC-based startup that is working on a new…
Read More
QIAGEN Launches Empowered Genome Community, Invites Citizen Scientists and Researchers to Pool and Collaboratively Interpret Human Genomes – MarketWatch
QIAGEN N.V. (frankfurt prime standard:QIA) today announced the Empowered Genome Community, which is a first-of-its-kind initiative to help people who have had their genomes…
Read More
Adventist HealthCare CEO: Don’t drop your company health plan – Washington Business Journal
A prominent health system CEO implored the Washington region's employers to not drop their company health plans in response to the Affordable Care Act,…
Read More
Schekman, Südhof Awarded 2013 Nobel Prize in Physiology or Medicine – Howard Hughes Medical Institute (HHMI.org)
The Nobel Assembly at the Karolinska Institute announced today that Randy W. Schekman, a Howard Hughes Medical Institute (HHMI) investigator at the University of…
Read More
Osiris will sell transplant therapy Prochymal and other assets in deal that could top $100M – Washington Post
Osiris Therapeutics shares rose Friday morning after the company said it is selling some of its stem cell therapy technology, including its transplant treatment…
Read More
Biotechnology Boom is Here to Stay, Investors Say – Venture Capital Dispatch – WSJ
There have been more than 30 initial public offerings of biotechnology companies so far this year, and there’s a line around the block of…
Read More
Intelligent Redesign of Health Care – Robert S. Kaplan, Thomas W. Feeley, Mary L. Witkowski , and Heidi W. Albright – Harvard Business Review
The health care industry has survived economically by cross-subsidizing margin shortfalls in one activity with the revenues generated from others. But the very existence…
Read More
MedImmune acquires biotech company Spirogen for $440 million
MedImmune, the global biologics research and development arm of AstraZeneca, has acquired Spirogen, a privately-held biotech company focused on antibody-drug conjugate technology for use…
Read More
MacroGenics shares climb following $80M IPO
Shares of MacroGenics are surging in Thursday midday trading after the biotechnology company raised $80 million in its initial public offering. MacroGenics sold 5…
Read More
The $100M Club: Where the Major League Life Sciences Companies Are – Xconomy
People love to rank U.S. biotech clusters. Most of these reports are full of data on venture financing, patents, jobs, and NIH funding. But…
Read More
How Obamacare could boost entrepreneurship – VentureBeat
Here’s what we know about the Affordable Care Act: 32 million Americans who would otherwise be uninsured will now have coverage. What you might…
Read More
UMD Researchers Are Developing a Robot That Crawls into Brains and Zaps Tumors – InTheCapital
If UMD researchers are well on their way to creating a robot that can wiggle through the brain to root out the tumors deep…
Read More
Mind the Gap Registration, Washington – Eventbrite
Tuesday, November 5, 2013 from 8:00 AM to 11:00 AM (EST) Join business, government and technology leaders for a high-level conversation on the transformation…
Read More
The Health IT Explosion: What Big Providers Want: Value Proposition, Pricing & Closing the Deal! – BHI Sponsored
October 16, 2013 at 6:00 PM - 8:00 PM Johns Hopkins - Montgomery County Campus The National Capitol Area Local Chapter of SoPE in…
Read More
Bioscience Networking Reception with Christopher P. Austin, M.D.
October 29th, 6:00pm National Center for Advancing Translational Sciences, Rockville, MD Please join us for an enhanced networking reception with leaders from the Mid-Atlantic…
Read More